Klin Farmakol Farm. 2006;20(4):219-222

Drug utilization study methodologies

Blanka Kořístková, Milan Grundmann
Ústav klinické farmakologie FNsP a ZSF Ostravské univerzity, Ostrava

Drug utilization expresses the exposition to a drug in the relationship to a given population group, in a given period and in a certain socio-economical background.

The volumes of the drugs distributed and of the prescription drugs issued are available on the national level. The amount of drugs issued on request forms in a certain medical institution is available on the local level. The utilization of non-prescription drugs is available in a local pharmacy. It is also possible to study the number of prescriptions according to the patient’s documentation.

Drug utilization may be expressed in numbers of packages, prescribed daily doses, defined daily doses (DDDs), patients, prescriptions or in costs. To make the comparison possible, it is important to use standard methodology – ATC/DDD, that is recommended by the World Health Organization, and recalculate the results to 1000 inhabitants (insureds) and a day in wholesale data (health insurance data), in medical institutions to 100 bed days or possibly to a patient.

DDD is the assumed average maintenance dose per day of a drug used for its main indication in adults. The utilization in DDD represents the exposition of individual substances, or possibly ATC units. DDD may not always reflect the actual prescribed daily dose in a given population. Drug utilization expressed in numbers of packages enables a correction for drugs without DDD (e.g. dermatologics). The costs provide information on the importance of the drug from an economical point of view.

Anatomical-therapeutic-chemical (ATC) system classifies drugs at five levels according to the organ or system on which they act and/or their therapeutic and chemical characteristics. The classification according to indication groups, used in the Czech Republic earlier, has only local character.

The State Institute for Drug Control provides on its web pages the conversion indexes from packages to the defined daily doses and ATC groups.

Keywords: Key words: utilization, ATC/DDD, prescribed daily dose, number of packages, costs, methodology.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kořístková B, Grundmann M. Drug utilization study methodologies. Klin Farmakol Farm. 2006;20(4):219-222.
Download citation

References

  1. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. 4th ed. Oslo, Norway, 2001.
  2. Vlček J, Macek K, Müllerová H, eds. Farmakoepidemiologie, farmakoekonomika, farmakoinformatika. Základy pro farmaceuty. 1. vyd. Praha: Panax Co, 1999.
  3. Wessling A, Boëthius G. Measurement of drug use in a defined population. Evaluation of the Defined Daily Dose (DDD) methodology. Eur J Clin Pharm 1990; 39 (3): 207-210. Go to original source... Go to PubMed...
  4. www.eurodurg.org.
  5. R nning M, Blix HS, Harb BT, Str m H. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose - are drug utilisation data comparable? Eur J Clin Pharmacol 2000; 56 (9-10): 723-727. Go to original source... Go to PubMed...
  6. Kořístková B, Grundmann M. Consumption of antiepileptics in big hospital with application drug utilization 90% method [abstrakt]. Brit J Clin Pharmacol 2000; Suppl: 90.
  7. Kořístková B, Grundmann M. Spotřeba antiarytmik a digoxinu [abstrakt]. In: Kvalita farmakoterapie v klinickej praxi. Abstrakty prednášok a posterov. 2. slovensko-česká konf. klin. farmakol. Nitra 2005.
  8. Merlo J, Wessling A, Melander A. Comparison of dose standard units for drug utilisation studies. Eur J Clin Pharmacol 1996; 50 (1-2): 27-30. Go to original source... Go to PubMed...
  9. Grundmann M, Kořístková B. Možnosti farmakoterapeutického auditu v nemocničních podmínkách [abstrakt]. In: sborník I. česko-slovenská konference klinické farmakologie. - Rožnov pod Radhoštěm, 2003: 20.
  10. www.aislp.cz, 25. 10. 2005.
  11. www.sukl.cz, 25. 10. 2005.
  12. http://www.sukl.cz/_download/cs11registrace/spotreba.doc, 25. 10. 2005.
  13. www.uzis.cz, 25. 10. 2005.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.